Next Gen Dx Summit Booth #28 August 23-26, 2016 Washington, DC www.nextgenerationdx.com Circulating Tumor Cell Program: Wed., August 24th at 12:50pm (Lunch Provided) Sensitive Assays to Detect Mutant ESR1 in Plasma Circulating Tumor DNA from Breast Cancer Patient Samples
qPCR & dPCR Congress October 20-21, 2016 London, UK www.globalengage.co.uk/qpcr.html Date: Thursday, October 20, 2016 at 10:05am-10:35am Title: The RainDrop dPCR system in a translational research environment: Methylation and Multiplexing on circulating tumour DNA. Speaker:
Abstract Minimal residual disease (MRD) in acute myelogenous leukemia (AML) is emerging as an independent risk factor for disease relapse and has significant potential to guide therapeutic decisions. However, current methods for detecting gene mutation-based MRD are limited by a lack
Abstract Targeted next-generation sequencing has become a critical tool for the interrogation of genomic events in myeloid malignancies. In this webinar, Dr. Eric Padron of the Moffitt Cancer Center, discussed his experience using the RainDance ThunderBolts Myeloid panel focusing on h
Abstract The RainDrop® Digital PCR System is the industry’s most sensitive instrument for researching nucleic acid detection and disease monitoring. Capable of producing up to 10 million picoliter sized droplets, the RainDrop Digital PCR System surpasses all existing technologies and
Abstract RainDance Technologies’ ThunderBolts™ Cancer Panel is a comprehensive next-generation DNA sequencing (NGS) solution. Our solution enables researchers to profile somatic mutations in a wide range of tumor samples in Superior coverage: 100% at ≥100x coverage depth for samples w
Abstract The RainDrop® Digital PCR System is a highly sensitive tool for precise quantification of nucleic acids using standard probe-based qPCR reagents. The system features an unprecedented multiplexing capability made possible by RainDance’s proprietary digital droplet technology p
RainDance Technologies is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.